Market Cap 1.05B
Revenue (ttm) 28.83M
Net Income (ttm) -162.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -564.90%
Debt to Equity Ratio 0.00
Volume 6,572,300
Avg Vol 4,227,188
Day's Range N/A - N/A
Shares Out 299.34M
Stochastic %K 6%
Beta 0.81
Analysts Strong Sell
Price Target $9.00

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research coll...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 West 4th Ave, Vancouver, Canada
tradersunion353
tradersunion353 Feb. 4 at 7:02 PM
$ABCL After being in downtrend for over an year Atleast for sake of long term investors this pos should have been trading minimum $4 Such a disappointment
1 · Reply
Odoji
Odoji Feb. 4 at 6:51 PM
0 · Reply
WenMoon9
WenMoon9 Feb. 4 at 6:43 PM
$ABCL or even 3.50 lol
1 · Reply
8008track
8008track Feb. 4 at 6:25 PM
$ABCL bought more today. Will we get back to $2?
1 · Reply
tkstockpicker
tkstockpicker Feb. 4 at 6:08 PM
$ABCL Man good think I only have a placeholder here, LOL
0 · Reply
Washingtonstate
Washingtonstate Feb. 4 at 5:37 PM
0 · Reply
DeMampCamp
DeMampCamp Feb. 4 at 4:07 PM
$ABCL Ok, someone apparently was fed up with this bs! Nasty dump just happened
2 · Reply
DeMampCamp
DeMampCamp Feb. 4 at 3:56 PM
$ABCL Down over 5% and trading where our "bottom" has been so what else can I do other than buy more! With that said, I still have to be smart and keep from getting every dime I have stuck in this market so I continue to have to reposition myself down here, I sure would LOVE to buy and be able to HOLD for a long ass time if it would stay away from these lows! I've accumulated over 56,000 shares here in the 3s
2 · Reply
PortfolioLighthouse
PortfolioLighthouse Feb. 4 at 3:05 PM
$ABCL is a clinical-stage biotech developing antibody-drug conjugates for cancer; its pipeline is early but promising, placing it in the high-risk, high-reward category typical of preclinical oncology biotechs.
0 · Reply
tradersunion353
tradersunion353 Feb. 4 at 3:03 PM
$ABCL 4.64 to 3.24 that is 30% drop in less than 2 weeks Longs here waiting for too long.. this needs to keep moving . I
0 · Reply
Latest News on ABCL
AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 3 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 3 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics: Entering Growth Phase After A Pause

Oct 6, 2025, 7:35 AM EDT - 4 months ago

AbCellera Biologics: Entering Growth Phase After A Pause


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 5 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:33 PM EDT - 9 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 9 months ago

AbCellera Reports Q1 2025 Business Results


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics: Still A Concept Stock

Dec 23, 2024, 4:39 PM EST - 1 year ago

AbCellera Biologics: Still A Concept Stock


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera: A Platform To Pipeline Transition

Oct 14, 2024, 12:04 PM EDT - 1 year ago

AbCellera: A Platform To Pipeline Transition


AbCellera: A Waiting Game With High Uncertainty

Aug 23, 2024, 4:43 AM EDT - 1 year ago

AbCellera: A Waiting Game With High Uncertainty


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


tradersunion353
tradersunion353 Feb. 4 at 7:02 PM
$ABCL After being in downtrend for over an year Atleast for sake of long term investors this pos should have been trading minimum $4 Such a disappointment
1 · Reply
Odoji
Odoji Feb. 4 at 6:51 PM
0 · Reply
WenMoon9
WenMoon9 Feb. 4 at 6:43 PM
$ABCL or even 3.50 lol
1 · Reply
8008track
8008track Feb. 4 at 6:25 PM
$ABCL bought more today. Will we get back to $2?
1 · Reply
tkstockpicker
tkstockpicker Feb. 4 at 6:08 PM
$ABCL Man good think I only have a placeholder here, LOL
0 · Reply
Washingtonstate
Washingtonstate Feb. 4 at 5:37 PM
0 · Reply
DeMampCamp
DeMampCamp Feb. 4 at 4:07 PM
$ABCL Ok, someone apparently was fed up with this bs! Nasty dump just happened
2 · Reply
DeMampCamp
DeMampCamp Feb. 4 at 3:56 PM
$ABCL Down over 5% and trading where our "bottom" has been so what else can I do other than buy more! With that said, I still have to be smart and keep from getting every dime I have stuck in this market so I continue to have to reposition myself down here, I sure would LOVE to buy and be able to HOLD for a long ass time if it would stay away from these lows! I've accumulated over 56,000 shares here in the 3s
2 · Reply
PortfolioLighthouse
PortfolioLighthouse Feb. 4 at 3:05 PM
$ABCL is a clinical-stage biotech developing antibody-drug conjugates for cancer; its pipeline is early but promising, placing it in the high-risk, high-reward category typical of preclinical oncology biotechs.
0 · Reply
tradersunion353
tradersunion353 Feb. 4 at 3:03 PM
$ABCL 4.64 to 3.24 that is 30% drop in less than 2 weeks Longs here waiting for too long.. this needs to keep moving . I
0 · Reply
Plutten1973
Plutten1973 Feb. 4 at 2:52 PM
$ABCL Hopefully we reach bottom soon at a tripple bottom hahaha i remember i have been writing this before hahaha
0 · Reply
BondAurora
BondAurora Feb. 4 at 2:30 PM
$ABCL is a clinical-stage biotech developing antibody-drug conjugates for cancer; its pipeline is promising but remains in early-stage development.
1 · Reply
DeMampCamp
DeMampCamp Feb. 4 at 2:20 PM
$ABCL Something I really didn't think about until a few minutes ago. It's no secret that software\AI companies have been hti extremely hard lately, is it possible that AbCellera is caught up in that category? That might explain the ridiculous drop we've had recently. Thoughts?
2 · Reply
AStrokeOfLuck
AStrokeOfLuck Feb. 3 at 10:01 PM
0 · Reply
tradersunion353
tradersunion353 Feb. 3 at 8:22 PM
$ABCL Can we just get one good news drop and open at $8 already?
1 · Reply
tradersunion353
tradersunion353 Feb. 3 at 6:38 PM
$ABCL Stock performance has become so disappointing recently. Lomg term shareholders including me are holding this forever
2 · Reply
8008track
8008track Feb. 3 at 5:57 PM
$ABCL we shall see if this ends up being a home run or not. Remember this: you have to be a contrarian to find hidden gems. There are a ton of people (betting hundreds of millions) that do not believe that AbCellera is going to work out. Or they think the overall market is about to go to zero or whatever. They may think $ABCL is burning money and that their tech isn’t going to work out as effectively as we think or whatever. Every time you buy, someone sold to you because they wanted to get out. My point is that you have to build your own conviction in a company in order to hold long term and see it through. This is either going to work out or it isn’t. If you believe they have superior tech and knowledge, then any drop in price should be considered a gift.
1 · Reply
DeMampCamp
DeMampCamp Feb. 3 at 4:21 PM
$ABCL Assholes all over the ASK, not feeling very confident at all lately
1 · Reply
Ckkung71
Ckkung71 Feb. 3 at 4:06 PM
$ABCL 3 weeks until q4 2026. A good year with lots of great news. Phases moving forward. A time plan running almost better than plans. Lot of cash. New molecules as planed. There is only one thing and it’s most be the one thing the shorters hope. The income from partnerships have reduced. If more partnerships are present and the different between earnings and loses look better the market will se that the stock price is much to low. At least 5$. Any thoughts?
1 · Reply
tradersunion353
tradersunion353 Feb. 2 at 7:16 PM
$ABCL Sad to see this dropping and day like this when market is sharply up
1 · Reply
nUme22
nUme22 Feb. 2 at 6:24 PM
$ABCL under 3 again
1 · Reply
Samb2344
Samb2344 Feb. 2 at 5:50 PM
$ABCL I bought the dip so yall would stop complaining 🫡🤣
0 · Reply